Moreover, the usage of cardiac glycosides was connected with a greater threat of invasive breasts cancers (RR 1.30, 95?% CI 1.14C1.48) among post-menopausal females [73] as well as the occurrence of estrogen receptor-positive breasts cancers was significantly greater than that of estrogen receptor-negative breasts cancer in females taking cardiac glycosides Continue Reading